Fibrinolytic for Treatment of Intraventricular Haemorrhage

Fibrinolytic for Treatment of Intraventricular Hemorrhage: A Meta-Analysis and Systematic Review

Alexandra Baker and Krissia Rivera Perla 

Johns Hopkins Hospital, Baltimore, Maryland

Intraventricular haemorrhage is a significant cause of mortality and morbidity worldwide. Treating it with intraventricular fibrinolytic therapy via a catheter is becoming an increasingly utilized intervention. But what is the role of this treatment in hypertensive intraventricular haemorrhage patients and what are the effect sizes for survival as well as level of function at differing time points?

I’m Carmen Lahiff-Jenkins, Managing Editor of the International Journal of Stroke and I spoke to Alexandra Baker and Krissia Rivera Perla from John Hopkins Hospital, Baltimore, Maryland, they are the joint first editors for the article Fibrinolytic for Treatment of Intraventricular Haemorrhage: A Meta-Analysis and Systematic Review.